114 related articles for article (PubMed ID: 11071864)
21. Cloning and characterization of the human BAG-1 gene promoter: upregulation by tumor-derived p53 mutants.
Yang X; Pater A; Tang SC
Oncogene; 1999 Aug; 18(32):4546-53. PubMed ID: 10467399
[TBL] [Abstract][Full Text] [Related]
22. Structure of the bovine VASAP-60/PRKCSH gene, functional analysis of the promoter, and gene expression analysis.
Brûlé S; Sayasith K; Sirois J; Silversides DW; Lussier JG
Gene; 2007 Apr; 391(1-2):63-75. PubMed ID: 17250974
[TBL] [Abstract][Full Text] [Related]
23. Major vault protein does not play a role in chemoresistance or drug localization in a non-small cell lung cancer cell line.
Huffman KE; Corey DR
Biochemistry; 2005 Feb; 44(7):2253-61. PubMed ID: 15709737
[TBL] [Abstract][Full Text] [Related]
24. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
25. 3-Methylcholanthrene inactivates the p53 gene in Syrian hamster embryo fibroblasts by inducing a specific intronic point mutation.
Albor A; Flessate DM; Soussi T; Notario V
Cancer Res; 1994 Aug; 54(16):4502-7. PubMed ID: 8044802
[TBL] [Abstract][Full Text] [Related]
26. The gonadotropin-regulated long-chain acyl CoA synthetase gene: a novel downstream Sp1/Sp3 binding element critical for transcriptional promoter activity.
Sheng Y; Li J; Dufau ML; Tsai-Morris CH
Gene; 2005 Oct; 360(1):20-6. PubMed ID: 16125341
[TBL] [Abstract][Full Text] [Related]
27. p53 involvement in activation of the cytokeratin 8 gene in tumor cell lines.
Mukhopadhyay T; Roth JA
Anticancer Res; 1996; 16(1):105-12. PubMed ID: 8615594
[TBL] [Abstract][Full Text] [Related]
28. Genomic organization, promoter activity, and expression of the human choline transporter-like protein 1.
Yuan Z; Tie A; Tarnopolsky M; Bakovic M
Physiol Genomics; 2006 Jun; 26(1):76-90. PubMed ID: 16609143
[TBL] [Abstract][Full Text] [Related]
29. Isolation and functional analysis of alternative promoters in the human aquaporin-4 water channel gene.
Umenishi F; Verkman AS
Genomics; 1998 Jun; 50(3):373-7. PubMed ID: 9676432
[TBL] [Abstract][Full Text] [Related]
30. The core promoter region of the P-glycoprotein gene is sufficient to confer differential responsiveness to wild-type and mutant p53.
Zastawny RL; Salvino R; Chen J; Benchimol S; Ling V
Oncogene; 1993 Jun; 8(6):1529-35. PubMed ID: 8502478
[TBL] [Abstract][Full Text] [Related]
31. Tumour-specific arginine vasopressin promoter activation in small-cell lung cancer.
Coulson JM; Stanley J; Woll PJ
Br J Cancer; 1999 Aug; 80(12):1935-44. PubMed ID: 10471042
[TBL] [Abstract][Full Text] [Related]
32. Direct activation of the human major vault protein gene by DNA-damaging agents.
Shimamoto Y; Sumizawa T; Haraguchi M; Gotanda T; Jueng HC; Furukawa T; Sakata R; Akiyama S
Oncol Rep; 2006 Mar; 15(3):645-52. PubMed ID: 16465425
[TBL] [Abstract][Full Text] [Related]
33. The region 3' to the major transcriptional start site of the MDR1 downstream promoter mediates activation by a subset of mutant P53 proteins.
Strauss BE; Haas M
Biochem Biophys Res Commun; 1995 Dec; 217(1):333-40. PubMed ID: 8526930
[TBL] [Abstract][Full Text] [Related]
34. Regulation of major vault protein expression by upstream stimulating factor 1 in SW620 human colon cancer cells.
Ikeda R; Nishizawa Y; Tajitsu Y; Minami K; Mataki H; Masuda S; Furukawa T; Akiyama S; Yamada K; Takeda Y
Oncol Rep; 2014 Jan; 31(1):197-201. PubMed ID: 24173679
[TBL] [Abstract][Full Text] [Related]
35. The Mr 193,000 vault protein is up-regulated in multidrug-resistant cancer cell lines.
Schroeijers AB; Siva AC; Scheffer GL; de Jong MC; Bolick SC; Dukers DF; Slootstra JW; Meloen RH; Wiemer E; Kickhoefer VA; Rome LH; Scheper RJ
Cancer Res; 2000 Feb; 60(4):1104-10. PubMed ID: 10706131
[TBL] [Abstract][Full Text] [Related]
36. A splice variant of the neuron-restrictive silencer factor repressor is expressed in small cell lung cancer: a potential role in derepression of neuroendocrine genes and a useful clinical marker.
Coulson JM; Edgson JL; Woll PJ; Quinn JP
Cancer Res; 2000 Apr; 60(7):1840-4. PubMed ID: 10766169
[TBL] [Abstract][Full Text] [Related]
37. A small upstream open reading frame causes inhibition of human major vault protein expression from a ubiquitous mRNA splice variant.
Holzmann K; Ambrosch I; Elbling L; Micksche M; Berger W
FEBS Lett; 2001 Apr; 494(1-2):99-104. PubMed ID: 11297743
[TBL] [Abstract][Full Text] [Related]
38. Differential transactivation of human metallothionein-IIa in cisplatin-resistant and -sensitive cells.
Yang YY; Robbins PD; Lazo JS
Oncol Res; 1998; 10(2):85-98. PubMed ID: 9666516
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical detection of the human major vault protein LRP with two monoclonal antibodies in formalin-fixed, paraffin-embedded tissues.
Schroeijers AB; Scheffer GL; Flens MJ; Meijer GA; Izquierdo MA; van der Valk P; Scheper RJ
Am J Pathol; 1998 Feb; 152(2):373-8. PubMed ID: 9466563
[TBL] [Abstract][Full Text] [Related]
40. Molecular basis for the expression of major vault protein induced by hyperosmotic stress in SW620 human colon cancer cells.
Tajitsu Y; Ikeda R; Nishizawa Y; Mataki H; Che XF; Sumizawa T; Nitta M; Yamaguchi T; Yamamoto M; Tabata S; Akiyama S; Yamada K; Furukawa T; Takeda Y
Int J Mol Med; 2013 Sep; 32(3):703-8. PubMed ID: 23820674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
